Implantable Cardioverter Defibrillator (ICD)

This channel includes news and new technology innovations for implantable cardioverter defibrillators (ICD) used to treat tachycardia arrhythmias and heart failure. This includes cardiac resynchronization therapy defibrillators (CRT-D).

A device programmer showing the suspension of ICD therapies (orange bar, red arrow) with iPhone 12 laying over patient’s chest (green arrow) and fluoroscopy of iPhone 12 showing the circular magnet array (yellow arrow). iPhone 12 can cause ICDs to stop working

A device programmer showing the suspension of ICD therapies (orange bar, red arrow) with iPhone 12 laying over patient’s chest (green arrow) and fluoroscopy of iPhone 12 showing the circular magnet array (yellow arrow). Read the full study

News | Implantable Cardioverter Defibrillator (ICD) | January 08, 2021
iPhone 12 May Cause Implantable Cardioverter Defibrillators to Malfunction
January 8, 2020 — A new study published this week in HeartRhythm, the journal of the Heart Rhythm Society (HRS), found...
read more
Videos | EP Device Monitoring Systems | December 22, 2020
VIDEO: Rising Interest in Remote Monitoring of EP Devices in the COVID-19 Era
Robert Kowal, M.D., chief medical officer of the Medtronic cardiac rhythm and heart failure division, said there has...
read more
Chest X-ray, posteroanterior view, of a 79-year-old man with history of a previous pacemaker, with abandoned right atrial and right ventricular pacing leads on the right side at time of new cardiac resynchronization therapy defibrillator implant on the left side. Arrows indicate a nodular opacity in the right midlung concerning for mass. Find more images of patients in this study in Radiology: Cardiothoracic Imaging.

Chest X-ray from a patient included in the study. Posteroanterior view, of a 79-year-old man with history of a previous pacemaker, with abandoned right atrial and right ventricular pacing leads on the right side at time of new cardiac resynchronization therapy defibrillator implant on the left side. Arrows indicate a nodular opacity in the right midlung concerning for mass. Find more images of patients in this study in Radiology: Cardiothoracic Imaging.

Feature | Magnetic Resonance Imaging (MRI) | October 27, 2020
MRI Can Be Safely Performed in Patients With Pacemakers and ICDs
October 27, 2020 – Magnetic resonance imaging (MRI) examinations can be safely performed in patients with non-MR...
read more
Biotronik's closed loop stimulation (CLS) technology helps reduce unexplained fainting in patients with recurrent episodes due to skipped heartbeats. #ESC2020
News | EP Lab | September 08, 2020
Study Shows Severe Fainting Can Be Treated with Cardiac Pacing Supported by Closed Loop Stimulation
September 8, 2020 - A new study presented at the 2020 European Society of Cardiology (ESC) Congress shows that...
read more
FDA Clears Abbott Gallant ICD and CRT With Bluetooth Connectivity and Continuous Remote Monitoring
News | EP Lab | July 13, 2020
FDA Clears Abbott Gallant ICD and CRT With Bluetooth Connectivity and Continuous Remote Monitoring
July 13, 2020 - The U.S. Food and Drug Administration (FDA) has approved Abbott's next-generation Gallant implantable...
read more
Videos | HRS | May 22, 2020
VIDEO: Top New EP Technologies at Heart Rhythm Society 2020
Interview with Andrew D. Krahn, M.D., FHRS, head of the division of cardiology at St. Paul’s Hospital, and professor of...
read more
Medtronic Cobalt and Crome ICD
News | EP Lab | May 12, 2020
FDA Approves Medtronic Cobalt and Crome ICD Portfolio
May 12, 2020 — Medtronic has received U.S. Food and Drug Administration (FDA) approval for its Cobalt and Crome ...
read more
The global, prospective, non-randomized UNTOUCHED study evaluated the safety and efficacy of the Boston Scientific Emblem S-ICD System – the only approved implantable defibrillator without wires touching the heart – for primary prevention of sudden cardiac death specifically in patients with a left ventricular ejection fraction (LVEF) ≤35 percent, the most common population to be indicated for ICD therapy. #Heartrhythm2020 #HRS20 #HRS2020
News | Implantable Cardioverter Defibrillator (ICD) | May 08, 2020
UNTOUCHED Trial Data Underscores Safety And Efficacy Of Boston Scientific S-ICD System
May 8, 2020 — Final results from the UNTOUCHED study of the Emblem Subcutaneous Implantable Defibrillator (S-ICD)...
read more
The Boston Scientific Emblem MRI-safe S-ICD system does not require a transvenous lead, leading to fewer complications with this type of ICD.

The Boston Scientific Emblem MRI-safe S-ICD system does not require a transvenous lead, leading to fewer complications with this type of ICD.

Feature | Implantable Cardioverter Defibrillator (ICD) | May 08, 2020
Head-to-head Comparison Shows Subcutaneous ICDs Safer Than Transvenous Defibrillators 
May 8, 2020 — A new clinical trial is the first to compare the safety and efficacy of subcutaneous implantable...
read more
Valentina Kutyifa, M.D., Ph.D., University of Rochester Medical Center, Rochester, N.Y., is doing research in the BIO-LIBRA Study to determine it ICD or CRT-D devices work better in men or women with heart failure often present with non-ischemic cardiomyopathy.

Valentina Kutyifa, M.D., Ph.D., University of Rochester Medical Center, Rochester, N.Y., is doing research in the BIO-LIBRA Study to determine it ICD or CRT-D devices work better in men or women with heart failure often present with non-ischemic cardiomyopathy.

Feature | Cardiac Resynchronization Therapy Devices (CRT) | March 09, 2020 | Valentina Kutyifa M.D., Ph.D.
BIO-LIBRA Study Evaluates Role of Sex and Device Type in Non-ischemic Cardiomyopathy
Cardiovascular disease is the leading cause of death for women in North America, and women with heart failure often...
read more
Earlier this year, Medtronic began a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms. The EV ICD system is designed to deliver lifesaving defibrillation and pacing therapy via a device the same size as traditional, transvenous ICDs, but with a lead (thin wire) placed outside the heart and veins. The future of CRM device technology.

Earlier this year, Medtronic began a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms. The EV ICD system is designed to deliver lifesaving defibrillation and pacing therapy via a device the same size as traditional, transvenous ICDs, but with a lead (thin wire) placed outside the heart and veins.

Feature | EP Lab | November 11, 2019 | Hrishikesh Kadam
The Future of Cardiac Rhythm Management Device Technology
Cardiac rhythm management (CRM) devices in use today are evolving to raise the bar beyond monitoring and managing...
read more
One of the cardiology technologies in the list of top advances in 2019 is Medtronic’s Tyrx Absorbable Antibacterial Envelope using to enclose cardiac implantable electronic devices (CIEDs). It reduced the risk of major infection by 40 percent, and pocket infection by 61 percent, based on data presented at ACC 2019.

One of the cardiology technologies in the list of top advances in 2019 is Medtronic’s Tyrx Absorbable Antibacterial Envelope using to enclose cardiac implantable electronic devices (CIEDs). It reduced the risk of major infection by 40 percent, and pocket infection by 61 percent, based on data presented at ACC 2019.

News | November 06, 2019
Cleveland Clinic Unveils Top 10 Medical Innovations for 2020
November 6, 2019 — Cleveland Clinic announced the Top 10 Medical Innovations for 2020 at a multimedia presentation last...
read more
Medtronic Initiates Worldwide Pivotal Study of Extravascular Implantable Cardioverter Defibrillator
News | Implantable Cardioverter Defibrillator (ICD) | October 11, 2019
Medtronic Initiates Worldwide Pivotal Study of Extravascular Implantable Cardioverter Defibrillator
October 11, 2019 — Medtronic plc announced the start of a worldwide pivotal study evaluating its investigational...
read more
Early ICD Use Prolongs Survival After Coronary Stenting
News | Implantable Cardioverter Defibrillator (ICD) | September 18, 2019
Early ICD Use Prolongs Survival After Coronary Stenting
September 18, 2019 — Early use of an implantable cardioverter-defibrillator (ICD) after primary coronary intervention...
read more
Abbott Recalls Ellipse Implantable Cardioverter Defibrillators Due to Exposed Aluminum Wires
News | Leads Implantable Devices | August 05, 2019
Abbott Recalls Ellipse Implantable Cardioverter Defibrillators Due to Exposed Aluminum Wires
August 5, 2019 — Abbott is recalling the Ellipse Implantable Cardioverter Defibrillators (ICDs) because electrical...
read more
© Copyright Wainscot Media. All Rights Reserved.